EP4279593A1 - DNA APTAMER, PHARMACEUTICAL COMPOSITION COMPRISING SAME, METHOD FOR INHIBITING CATALYTIC ABILITY OF TXNDC5, AND METHOD FOR PREVENTING OR TREATING ORGAN FIBROSIS